- Home
- IMVT vs PTON Comparison
IMVT vs PTON Comparison
Compare IMVT & PTON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- PTON
- Stock Information
- Founded
- IMVT 2018
- PTON 2012
- Country
- IMVT United States
- PTON United States
- Employees
- IMVT N/A
- PTON N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- PTON Recreational Games/Products/Toys
- Sector
- IMVT Health Care
- PTON Consumer Discretionary
- Exchange
- IMVT Nasdaq
- PTON Nasdaq
- Market Cap
- IMVT 2.8B
- PTON 2.9B
- IPO Year
- IMVT N/A
- PTON 2019
- Fundamental
- Price
- IMVT $15.80
- PTON $6.18
- Analyst Decision
- IMVT Buy
- PTON Buy
- Analyst Count
- IMVT 10
- PTON 19
- Target Price
- IMVT $40.14
- PTON $7.78
- AVG Volume (30 Days)
- IMVT 1.3M
- PTON 15.5M
- Earning Date
- IMVT 08-05-2025
- PTON 05-08-2025
- Dividend Yield
- IMVT N/A
- PTON N/A
- EPS Growth
- IMVT N/A
- PTON N/A
- EPS
- IMVT N/A
- PTON N/A
- Revenue
- IMVT N/A
- PTON $2,527,400,000.00
- Revenue This Year
- IMVT N/A
- PTON N/A
- Revenue Next Year
- IMVT N/A
- PTON N/A
- P/E Ratio
- IMVT N/A
- PTON N/A
- Revenue Growth
- IMVT N/A
- PTON N/A
- 52 Week Low
- IMVT $12.72
- PTON $2.83
- 52 Week High
- IMVT $34.47
- PTON $10.90
- Technical
- Relative Strength Index (RSI)
- IMVT 53.39
- PTON 40.47
- Support Level
- IMVT $15.11
- PTON $6.04
- Resistance Level
- IMVT $17.08
- PTON $7.42
- Average True Range (ATR)
- IMVT 0.76
- PTON 0.48
- MACD
- IMVT -0.00
- PTON -0.15
- Stochastic Oscillator
- IMVT 47.56
- PTON 7.42
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About PTON Peloton Interactive Inc.
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of bike and tread and related accessories sales, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue is generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates maximum revenue from the Subscription segment. Geographically, the company derives a majority of its revenue from North America and the rest from the International markets.